the market?
Neuralstem Inc.
NYSEMKT: CUR
1.43
0.00
(0.00%)
| Today's Open | $1.44 |
|---|---|
| Previous Close | $1.43 |
| Daily Range | $1.38 - $1.45 |
| 52-Week Range | $0.42 - $1.96 |
| Market Cap | $98.4M |
| P/E Ratio | -8.41 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 325,761 |
| Average Daily Volume | 604,412 |
| Current FY EPS | -$0.16 |
How do you think CUR
will perform against the market?
Top CUR Bull/Bear Pitches
zzlangerhans (< 20)
Submitted
February 24, 2011
Despite their precarious financial position the one year low for Neuralstem is 1.8. I'm going to try and jump in for a quick rebound on a volatile stock, but if I get caught in the dilution downdraft … More
geneticbiscuit (< 20)
Submitted
May 4, 2010
Probably a bit early on this underperform call, but this recent run on news of entering Phase I trials for their stem cell treatments for ALS is a bit ridiculous.<br />With less than 5 million in the … More
News & Commentary
Cloning: A Stem Cell Revolution?
Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?FDA OKs Neuralstem Trial Treating Spinal Cord Injuries With Stem Cells
NSI-566 has already shown promise in ALS and rat models of spinal cord injuries.CAPScall of the Week: Neuralstem
A weekly adventure in giving unknown companies some attention.Sector
Healthcare
Industry
Drugs
Neuralstem Inc. (CUR) Description
Neuralstem Inc is an biotechnology company which is engaged on developing and commercializing human neural stem cell technology in the emerging field of regenerative medicine. Website: http://www.neuralstem.com/
